Recursion Pharmaceuticals Inc (NASDAQ:RXRX) Achieved Almost -0.22% Growth In A Month. Also Looks Good Long Term.
In recent trading session, Recursion Pharmaceuticals Inc (NASDAQ:RXRX) saw 0.72 million shares changing hands at last check today with its beta currently measuring 0.80. Company’s